In a report released today, Justin Smith from Bernstein maintained a Buy rating on AstraZeneca (AZN – Research Report), with a price target of ...

Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...

As per the reported property consultants, the company has issued a global mandate for selecting candidates for the said land ...

With the rising incidence of cancer in India, AstraZeneca India's breast cancer medicine trastuzumab deruxtecan (sold under ...

Shares of Vodafone Idea (Vi) dropped nearly 2 percent and are currently trading at around Rs 8.94 per share. The company is ...

Decision puts spotlight on Lord Hermer, who represented the former Sinn Fein leader in a separate compensation case ...

National Institutes of Health (NIH) scientists and their colleagues report that a single dose of a broadly neutralizing antibody (bnAb) administered prior to virus exposure protects macaques from ...

Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, today ...

Portfolio Receipts of $742 million in Q4 2024 and $2,801 million for FY 2024Royalty Receipts growth of 12% in Q4 2024 and 13% for FY 2024 Net cash provided by operating activities of $743 million in ...

Pliant Therapeutics paused its phase 2b/3 trial of bexotegrast for idiopathic pulmonary fibrosis due to DSMB recommendations.

Glox Therapeutics has appointed of Michael Murray as chair of its board. He will work with the leadership team to accelerate ...